-
What does it mean to go from "recruitment" to "price acquisition"?
Time of Update: 2022-06-16
According to China Medical Insurance, the only media platform of the National Medical Insurance Bureau, in the report of the National Pharmaceutical Centralized Purchasing Agency Work Conference, the work of the Jiangxi Provincial Centralized Purchasing Agency was specially mentioned: Jiangxi Provincial Medicine Price and Purchasing Service Center actively innovated, Increase institutional functions, make up for the shortcomings of medical service price project management, and realize the transformation and remodeling from "recruitment center" to "price procurement center" .
-
Precautions for daily use of automatic bottle unscrambler
Time of Update: 2022-06-16
3. After turning off the power switch of the bottle unscrambler, there is still a strong voltage in some circuits in the electrical control of the machine.
If you need to repair the control circuit, you must unplug the power cord to avoid electric shock .
-
KRAS G12C Inhibitors: From Single Drug Competition to Combination Therapy Breakthrough
Time of Update: 2022-06-16
Amgen broke the saying that KRAS targets cannot be medicines, and also made global pharmaceutical companies restless, and everyone followed up the research and development of KRAS G12C inhibitors .
Amgen announced two years of long-term follow-up data on sotorasib in KRAS G12C-mutated non-small cell patients .
-
Past and present life of medicinal excipients Lecithos
Time of Update: 2022-06-16
The CAS of Lecithin is 8002-43-5, which is defined as phosphatidylcholine in all animal and plant tissues, which can be used as lubricants, emulsifiers, and food additives; the CAS number of soybean lecithin is 8030-76-0, which is extracted from soybean The phospholipid mixture is mainly used for health care products and non-injection drugs.
-
Placement Conditions for Small Heating Circulators
Time of Update: 2022-06-16
If they are not placed as required, it is not conducive to the operation of small heating cycle devices .
In order to obtain stable performance of the small heating cycle device, the installation room should be air-conditioned to keep it operating at a normal room temperature .
-
How to solve the common faults of multi-functional crusher
Time of Update: 2022-06-16
If it is not well connected during the assembly process, it will cause the overall vibration of the multi-functional pulverizer .
The reason is that the connection between the coupling and the rotor is not concentric or the quality of the crushing hammer is not uniform .
-
In 2022, the patents of these 29 original research drugs will expire!
Time of Update: 2022-06-16
With the normalized implementation of centralized procurement in recent years, generic drug companies are facing huge competition and transformation pressure . How to comply with policy trends, how
-
Temperature Control Factors of Reactor Heating Refrigeration Cycle Machine
Time of Update: 2022-06-16
The heating/cooling equipment injects constant temperature (high temperature or low temperature) heat transfer oil or refrigerant to heat or cool the materials in the reactor at constant temperature .
-
The wave of layoffs in multinational pharmaceutical companies is coming
Time of Update: 2022-06-16
In addition, according to the official account of Medical Cube invest, Huizhi, Merck, and GSK will reduce the number of employees by more than 5,000 in 2021 .
The significant reduction in the number of employees this time is related to the company's restructuring plan .
-
How much do you know about the isolation explosion-proof heating and refrigeration cycle machine?
Time of Update: 2022-06-16
Check whether the fastening bolts of the power wiring of the isolation explosion-proof heating and cooling cycle machine are loose .
The design of the refrigeration circuit of the isolation explosion-proof heating and refrigeration cycle machine and the control of the temperature of the components are very important .
-
The annual report of NMPA drugs after listing, and the comparison with FDA annual report requirements
Time of Update: 2022-06-16
The main points of NMPA's "Regulations on the Administration of Drug Annual Reports" definitiondefinition Annual report refers to the report that the holder collects the production and sales, post-marketing research, risk management, etc.
-
In the second half of the industry, what will innovative pharmaceutical companies bet on tomorrow?
Time of Update: 2022-06-16
With the release of the annual reports of various pharmaceutical companies this year, Junshi relies on the new crown monoclonal antibody to greatly compensate for the lack of performance growth of the core product PD-1 in several Biotechs .
-
4 new drugs were approved for new indications in China, from Novartis, Merck, Roche, Chia Tai Tianqing
Time of Update: 2022-06-16
Recently, the official website of China's National Medical Products Administration (NMPA) announced that a number of new drugs have been approved for new indications in China, including Novartis' innovative biological agent omalizumab, Merck's (MSD) antifungal drug posaconazole, Roche (Roche) anti-IL-6R antibody tocilizumab, Chia Tai Tianqing multi-target tyrosine kinase inhibitor (TKI) anlotinib, etc.
-
10 Therapies With Structures First Announced at AACR
Time of Update: 2022-06-16
Uveal melanoma and hematological cancer cell lines are particularly sensitive to BAF complex inhibitors Related reading: PROTAC combined with CRISPR screening, promising in this anti-cancer field Drug Candidate: EZM0414, Histone Methyltransferase SETD2 InhibitorDrug Candidate: EZM0414, Histone Methyltransferase SETD2 Inhibitor R&D organization: EpizymeR&D organization: Epizyme ▲ Molecular formula of EZM0414 (Image source: Reference [1])▲ Molecular formula of EZM0414 (Image source: Reference [1]) EZM0414, like FHD-286 and CFT8634 mentioned above, is designed to treat cancer by targeting epigenetic mechanisms .
-
The death rate is reduced by 55%!
Time of Update: 2022-06-16
A Veru spokesperson said that sabizabulin is the first drug to significantly reduce mortality in hospitalized patients with moderate to severe Covid-19, a fact supported by solid clinical evidence and statistical data .
-
Definition of flexible packaging film and introduction of its barrier technology
Time of Update: 2022-06-15
The plastic film is transparent, flexible, has good water resistance, moisture resistance and gas barrier properties, good mechanical strength, stable chemical properties, oil resistance, easy to print exquisite pictures and texts, and can be heat-sealed to make bags .
-
How to ensure the temperature range of the biological heating refrigeration cycle machine
Time of Update: 2022-06-15
The biological heating refrigeration cycle machine is mostly used to control the temperature of glass or metal reactors in the fields of chemical and pharmaceutical research .
Many enterprises, especially chemical, pharmaceutical and other industries need to use biological heating refrigeration cycle machines in the production process.
-
WuXi is a dominant company, how does the local biopharmaceutical CDMO walk out of the differentiated route?
Time of Update: 2022-06-15
The biopharmaceutical market continues to rise, and biopharmaceutical CDMOs take advantage of the trendBiopharmaceutical CDMOs take advantage of the momentum In 2002, after the world's first fully human monoclonal antibody drug adalimumab (trade name: Humira, English trade name Humira) was launched, the global biopharmaceutical field started 20 years of rapid development and still has great growth potential .
-
Potential therapeutic areas and hot targets of generic drugs!
Time of Update: 2022-06-15
Table 1: 2025 Market Scale Forecast for Expired Drugs by Therapeutic Area/Generic Name Source: Cortellis, organized by China Pharmaceutical Industry Information Center The following is a sample hospital drug market performance of the six potential therapeutic areas of digestive system drugs, nervous system drugs, endocrine and metabolic regulation drugs, mental disorder drugs, urinary system drugs, and anti-tumor drugs, and the key indications in these fields.
-
Up to $225 million: Eli Lilly and Telix Pharmaceuticals reach licensing deal for olaratumab
Time of Update: 2022-06-15
Olaratumab was originally developed by Eli Lilly as a (non-radiolabeled) monoclonal antibody targeting platelet-derived growth factor receptor alpha (PDGFRα) and was approved by the FDA in October 2016 for the treatment of adult soft tissue sarcoma (STS) .
com/news-media/telix-announces-licence-agreement-with-lilly-for-olaratumab/https://telixpharma.
